1. Home
  2. EFOI vs OGEN Comparison

EFOI vs OGEN Comparison

Compare EFOI & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFOI

Energy Focus Inc.

HOLD

Current Price

$3.09

Market Cap

21.0M

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.55

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
OGEN
Founded
1985
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
2.8M
IPO Year
2004
2010

Fundamental Metrics

Financial Performance
Metric
EFOI
OGEN
Price
$3.09
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
20.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
N/A
EPS
N/A
N/A
Revenue
$3,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.48
52 Week High
$9.84
$1.45

Technical Indicators

Market Signals
Indicator
EFOI
OGEN
Relative Strength Index (RSI) 54.30 48.99
Support Level $2.83 $0.49
Resistance Level $3.37 $0.61
Average True Range (ATR) 0.14 0.04
MACD 0.04 0.01
Stochastic Oscillator 71.19 55.16

Price Performance

Historical Comparison
EFOI
OGEN

About EFOI Energy Focus Inc.

Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Share on Social Networks: